Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005017
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2000-04-03
Brief Title:
Effectiveness and Safety of EpivirZiagenZerit 3TCABCd4T Versus EpivirZiagenSustiva 3TCABCEFV Versus EpivirZiagenAgeneraseNorvir 3TCABCAPVRTV in HIV Patients Who Have Never Received Treatment
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
264N
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Glaxo Wellcome
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None